Buch, Englisch, 249 Seiten, HC runder Rücken kaschiert, Format (B × H): 160 mm x 241 mm, Gewicht: 5751 g
A distant goal
Buch, Englisch, 249 Seiten, HC runder Rücken kaschiert, Format (B × H): 160 mm x 241 mm, Gewicht: 5751 g
ISBN: 978-94-017-9164-9
Verlag: Springer Netherlands
Based on 30 years of clinical and research experience, backed by a careful assessment of four decades of published data, Dr. Faguet documented in The War on Cancer (Springer 2005), early advances in cancer treatment and patient survival that soon stalled. Ten years later and after an exhaustive analysis of evidence-based data available through 2013 that incorporates 755 references, he reveals the root causes of the stagnation in cancer control, including the role played by major stakeholders and advocates a coordinated national effort, akin to the Apollo program, to unveil the causes of cancer and their mastery. In the interim, Dr. Faguet urges caregivers to manage patients according to the four ethical principles of beneficence, non-maleficence, respect for patients’ autonomy and justice especially at the end of life.
Zielgruppe
Research
Autoren/Hrsg.
Fachgebiete
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Vorklinische Medizin: Grundlagenfächer Molekulare Medizin, Zellbiologie
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Onkologie, Krebsforschung
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Vorklinische Medizin: Grundlagenfächer Humangenetik
Weitere Infos & Material
Preface. Part I An Historical overview of the war on cancer. The four-decade journey to the National Cancer Act of 1971. Part II Cancer through the ages.- An historical overview: From prehistory to WW11.- Our current knowledge.- Environmental carcinogens.- Part III Cancer statistics.- Assessing the enormity of the problem.- An uncontrolled problem.- Part IV How is advanced cancer treated?-The cancer-cell kill paradigm and beyond.- Complementary and alternative medicine.- The cell-kill paradigm: Bleak outcomes. Part V Stakeholders' role in the status quo.- The role of the National Cancer Institute.- Factors that impact Oncology research and practice.- The complex physician-patient interaction: Expectations vs. reality. Part VI A paradigm shift in cancer management.- Prevention & Early detection.- The holistic management of advanced cancer: A three-stage blueprint. Conclusions. References. Index.